Impaired Wound Healing of Alveolar Lung Epithelial Cells in a Breathing Lung-On-A-Chip
Overview
Authors
Affiliations
The lung alveolar region experiences remodeling during several acute and chronic lung diseases, as for instance idiopathic pulmonary fibrosis (IPF), a fatal disease, whose onset is correlated with repetitive microinjuries to the lung alveolar epithelium and abnormal alveolar wound repair. Although a high degree of mechanical stress (>20% linear strain) is thought to potentially induce IPF, the effect of lower, physiological levels of strain (5-12% linear strain) on IPF pathophysiology remains unknown. In this study, we examined the influence of mechanical strain on alveolar epithelial wound healing. For this purpose, we adopted the "organ-on-a-chip" approach, which provides the possibility of reproducing unique aspects of the cellular microenvironment, in particular its dynamic nature. Our results provide the first demonstration that a wound healing assay can be performed on a breathing lung-on-a-chip equipped with an ultra-thin elastic membrane. We cultured lung alveolar epithelial cells to confluence, the cells were starved for 24 h, and then wounded by scratching with a standard micropipette tip. Wound healing was assessed after 24 h under different concentrations of recombinant human hepatic growth factor (rhHGF) and the application of cyclic mechanical stretch. Physiological cyclic mechanical stretch (10% linear strain, 0.2 Hz) significantly impaired the alveolar epithelial wound healing process relative to culture in static conditions. This impairment could be partially ameliorated by administration of rhHGF. This proof-of-concept study provides a way to study of more complex interactions, such as a co-culture with fibroblasts, endothelial cells, or immune cells, as well as the study of wound healing at an air-liquid interface.
Gagnon K, Huang J, Hix O, Hui V, Hinds A, Bullitt E APL Bioeng. 2024; 8(2):026126.
PMID: 38911024 PMC: 11191334. DOI: 10.1063/5.0207228.
A miniaturized multicellular platform to mimic the 3D structure of the alveolar-capillary barrier.
Licciardello M, Traldi C, Cicolini M, Bertana V, Marasso S, Cocuzza M Front Bioeng Biotechnol. 2024; 12:1346660.
PMID: 38646009 PMC: 11026571. DOI: 10.3389/fbioe.2024.1346660.
An Insight on Microfluidic Organ-on-a-Chip Models for PM-Induced Pulmonary Complications.
Shah D, Dave B, Chorawala M, Prajapati B, Singh S, Elossaily G ACS Omega. 2024; 9(12):13534-13555.
PMID: 38559954 PMC: 10976395. DOI: 10.1021/acsomega.3c10271.
A roadmap for developing and engineering pulmonary fibrosis models.
Dabaghi M, Carpio M, Saraei N, Moran-Mirabal J, Kolb M, Hirota J Biophys Rev (Melville). 2024; 4(2):021302.
PMID: 38510343 PMC: 10903385. DOI: 10.1063/5.0134177.
Development of a Nanoparticle System for Controlled Release in Bioprinted Respiratory Scaffolds.
Zimmerling A, Sunil C, Zhou Y, Chen X J Funct Biomater. 2024; 15(1).
PMID: 38248687 PMC: 10816437. DOI: 10.3390/jfb15010020.